Beteiligungsmeldung
DocMorris AG
Gemeinsam gemeldeter Anteil
15.013%
Threshold
Crossed upwards
Timeline
Published
22.05.2026
Transaction
15.05.2026
Übertragungsdatum
19.05.2026
Voting rights breakdown
Gemeldete wirtschaftlich Berechtigte · 3
Eine einzelne, gemeinsam eingereichte Meldung: Der Stimmrechtsanteil gilt für die gesamte Gruppe, nicht für jede Person.
Notice details
Meldungs-ID
ZA02-000000000S2T5
Beneficial owner
Jacek Szwajcowski
Gemeldete Adresse
Jacek Szwajcowski, Lodz, PL
On 26.02.2026, Pelion S.A. and Corporation of European Pharmaceutical Distributors N.V. have entered into an agreement that Pelion S.A. will sell to Corporation of European Pharmaceutical Distributors N.V. all shares in DocMorris AG it holds within 20 business days following the completion of the Annual General Meeting 2026 of DocMorris AG (i.e. by 12 June 2026 the latest). Such sale was notified by notice published on 05 March 2026. The settlement date of such sale of shares from Pelion S.A. to Corporation of European Pharmaceutical Distributors N.V. is now fixed and is 19 May 2026. As both Pelion S.A. and Corporation of European Pharmaceutical Distributors N.V. are beneficially owned by Jacek Szwajcowski and Zbigniew Molenda, such sale of shares from Pelion S.A. to Corporation of European Pharmaceutical Distributors N.V. does not result in a change of the beneficial ownership of such shares of DocMorris AG but a change of the persons directly involved in the group.
insider24.ch
Verpassen Sie kein Marktsignal mehr
Mehr benötigt? Pro-Angebot entdecken